Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 19, 2018Journal of Clinical OncologyOpen Access

Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing

View Full Paper
Ask AI
Bookmark
Share

Authors

TSThomas P. SlavinUniversity of Hawaiʻi at MānoaKBKimberly C. BanksGuardant (United States)DCDarya ChudovaGuardant (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Slavin et al. (2018) studied this question.

synapsesocial.com/papers/69de491f210a0977fce93bf2https://doi.org/10.1200/jco.18.00328
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations2018 · 63 citations
  2. 2Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories: Table 1.2015 · 97 citations
  3. 3Genetic Testing and the Clinical Laboratory Improvement Amendments of 1988: Present and Future1999 · 56 citations
  4. 4Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing2011 · 946 citations
  5. 5Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies2018 · 445 citations